Watchful Waiting Strategy

Watchful waiting (also called 'active surveillance' or 'expectant management') is the deliberate clinical decision to not intervene immediately, instead monitoring the patient's condition for changes that would trigger action. For many conditions — low-grade prostate cancer, certain thyroid nodules, uncomplicated ear infections in children, early-stage osteoarthritis — the risks of immediate treatment (surgery complications, antibiotic resistance, side effects) outweigh the benefits when the condition may resolve spontaneously or progress slowly enough that delayed treatment is equally effective. The practitioner's challenge is distinguishing watchful waiting (active, purposeful monitoring with clear intervention triggers) from neglect (ignoring a problem and hoping it goes away).

When to use it

When the risks of immediate intervention may outweigh the risks of the condition, when conditions frequently resolve spontaneously, when you need to distinguish strategic patience from neglect, or when action bias is pushing you toward premature intervention.

How it can help

This model counters action bias — the deeply human tendency to do something, anything, rather than deliberately wait. In business, many problems resolve themselves if given time: team conflicts that work themselves out, market fluctuations that self-correct, technical glitches that are transient. The key insight is that 'wait and see' is a legitimate strategy ONLY when you define what you're watching for, set triggers for action, and actively monitor. Without these elements, it's just procrastination dressed up as strategy. The model also teaches that intervention has costs (side effects, disruption) that must be weighed against the costs of the condition itself.